-
28 Aug 2026
[Comment] Deep and durable lipoprotein(a) lowering: Kylo-11 advances RNA interference therapeutics
The Lancet
- Views 29
- More stats
-
28 Aug 2026
[Articles] Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
The Lancet
- Views 79
- More stats
-
28 Aug 2026
A FAIR road to a bioAFM databank
Nature Methods
- Views 48
- More stats
-
28 Aug 2026
Temporal analyses of immune responses in sepsis reveal asynchrony between clinical stage of illness and immune states
Immunity
- Views 101
- More stats
-
28 Aug 2026
A distinct effector B cell population drives autoantibody production in SARS-CoV-2 infection
Immunity
- Views 45
- More stats
-
28 Aug 2026
Uptake via the leaf surface allows plants to perceive volatiles with closed stomata
Current Biology
- Views 41
- More stats
-
28 Aug 2026
Whole-lake exposure to a widespread estrogenic pollutant leads to unanticipated reproductive behaviors in wild fish
Current Biology
- Views 31
- More stats
-
28 Aug 2026
Briefing Chat: How Dolly Parton left her mark on science
Nature
- Views 28
- More stats
-
28 Aug 2026
The Moderna cancer vaccine offers hope — now we must speed up personalized therapies
Nature
- Views 36
- More stats
-
28 Aug 2026
Cyclopropanol can function as a caged dual-functional warhead for selective electrochemical bioconjugation
Nature Chemistry
- Views 43
- More stats
Journal Content
Life Science Network features journal content imported from some of the most popular scientific journals. In addition, the Publications module allows you to import or add your own publications to our database. Note that the indicated journal impact factors are not regularly updated.
Check the Publications module here
Advertisement